Table 1.
Summary of tetracoordinated copper(II) complexes with better IC50 values (μM) in different cell lines.
Compound |
Metal geometry |
Exposure time [h] |
Cell lines |
IC50 value [μM] |
Main feature |
Ref. |
---|---|---|---|---|---|---|
Cu‐03 |
Square planar |
48 |
Hep‐G2 BEL‐7402 BEL‐7404 HL‐7702 |
7.27±0.26 8.66±0.22 11.84±0.31 12.02±0.16 |
Anticancer activity depends on the binding of the complex with HSA that acts as a drug delivery system |
[59] |
Cu‐04 |
Square planar |
Hep‐G2 BEL‐7402 BEL‐7404 HL‐7702 |
5.18±0.19 6.23±0.12 8.92±0.21 12.18±0.15 |
|||
Cu‐76 |
Tetrahedral |
HCT‐116 MCF‐7 |
3.26[a] 7.40[a] |
The anticancer activity depends on the positive charge of the central metal, the nature of the ligand and the hydrogen bonds |
[119] |
[a] μg μL−1.